MedicaidCoverageMedium impact
Genetic Testing for Diagnosis of Inherited Conditions - MEDICAID - FLORIDA (Revised)
Humana·FL · Genetics, Neurology, Ophthalmology +3 more·Medicaid
Effective date
Sep 2, 2026
We identified it
Sep 2, 2026
Summary
Humana Florida Medicaid has updated its genetic testing policy (effective 09/02/2026) establishing new coverage criteria and medical necessity requirements for genetic testing used to diagnose inherited conditions including adrenoleukodystrophy, corneal dystrophy, DRPLA, GSD I, hemophilia B, myotonic dystrophy, and other specified genetic disorders. The policy requires pre- and post-test genetic counseling and specific clinical criteria documentation for coverage eligibility.
Action Required
By 09/02/2026: Billing team and providers must implement the following: (1) Update billing system to require pre- and post-test genetic counseling documentation for all genetic testing claims under this policy; (2) Establish prior authorization workflow requiring submission of clinical criteria evidence for each condition (e.g., elevated VLCFA for adrenoleukodystrophy, ophthalmology exam findings for corneal dystrophy, presence of DRPLA symptoms); (3) Update encounter templates and order entry systems to include checkboxes for required clinical findings before genetic testing codes (81333, 81177, 81250, and others) can be billed; (4) Train providers on specific medical necessity criteria for each condition listed in Coverage Determination section; (5) Deny or request additional documentation for any genetic testing claims lacking evidence of required clinical criteria or genetic counseling. Add policy reference HUM-FL-2109-003 to compliance documentation.